Promoting Problem-Solving Among Low-Income Adults With Type 2 Diabetes: Cluster-Randomized Controlled Trial of a Mobile Health Intervention With SMS Text Messaging (Mobile Diabetes Detective) - Takeaways - MDSpire

Promoting Problem-Solving Among Low-Income Adults With Type 2 Diabetes: Cluster-Randomized Controlled Trial of a Mobile Health Intervention With SMS Text Messaging (Mobile Diabetes Detective)

  • By

  • Lena Mamykina

  • Arlene M Smaldone

  • Suzanne R Bakken

  • Heather Cole-Lewis

  • Elizabeth M Heitkemper

  • Haomiao Jia

  • Rita Kukafka

  • Jonathan N Tobin

  • Andrea Cassells

  • Patricia G Davidson

  • Elizabeth D Mynatt

  • George Hripcsak

  • July 13, 2026

Share

  • 1

    Problem-solving skills are crucial for effective type 2 diabetes management and improving clinical outcomes.

  • 2

    Mobile Diabetes Detective (MoDD) is an automated mHealth intervention designed to enhance problem-solving in diabetes self-management.

  • 3

    MoDD utilizes individuals' self-monitoring data to provide personalized problem-solving support tailored to glycemic challenges.

  • 4

    The study evaluated MoDD's efficacy through a cluster-randomized trial involving low-income adults with type 2 diabetes.

  • 5

    The primary outcome measured was the change in glycated hemoglobin (HbA1c) after 12 months of intervention.

Original Source(s)

Promoting Problem-Solving Among Low-Income Adults With Type 2 Diabetes: Cluster-Randomized Controlled Trial of a Mobile Health Intervention With SMS Text Messaging (Mobile Diabetes Detective)

  • by Lena Mamykina, Arlene M Smaldone, Suzanne R Bakken, Heather Cole-Lewis, Elizabeth M Heitkemper, Haomiao Jia, Rita Kukafka, Jonathan N Tobin, Andrea Cassells, Patricia G Davidson, Elizabeth D Mynatt, George Hripcsak

  • July 13, 2026

Related Content

Stage-dependent alterations of Sonoclot coagulation profiles across the spectrum of diabetic peripheral neuropathy

Association between triglyceride glucose index and odds of hip fracture in patients with or without type 2 diabetes: a cross-sectional study

A network meta-analysis of endocrine adverse events induced by immune checkpoint inhibitors in colorectal cancer